McKesson Corp. (MCK) Tops Q2 EPS by 6c, Offers FY Guidance

McKesson Corp. (NYSE: MCK) reported Q2 EPS of $2.79, $0.06 better than the analyst estimate of $2.73. Revenue for the quarter came in at $44.76 billion versus the consensus estimate of $42.99 billion.

McKesson Corp. sees FY2014 EPS of $10.50-$10.90, versus the consensus of $10.81.

For earnings history and earnings-related data on McKesson Corp. (MCK) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c